Webinar
The First 5 Months: Practical Implications of the JCA
In this learning session, “The First 5 Months: Practical Implications of the JCA,” our expert discusses the early experiences and insights gained from the implementation of the Joint Clinical Assessment (JCA) under the EU HTA regulation. Ann-Sophie Kuschel shares practical implications for stakeholders involved in the development and commercialization of cell and gene therapies, highlighting the unique challenges and considerations relevant to this process.
Explore and how the JCA impacts the landscape for advanced therapies in Europe to prepare to navigate this evolving regulatory environment.
Speaker:
- Ann-Sophie Kuschel - Principal at Vintura, a Cencora company
Fill out the form to watch the session
Pardot Form
